Evidence map›Paper›PMID 41193468›Full record

ArticleNature communications2025

Spatial single-cell atlas reveals regional variations in healthy and diseased human lung.

Alexandra B Firsova, Sergio Marco Salas, Louis B Kuemmerle, Xesús M Abalo, Alexandros Sountoulidis, Ludvig Larsson, Krishnaa T Mahbubani, Jonas Theelke, Zaneta Andrusivova, Leire Alonso Galicia and 17 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Alexandra B FirsovaScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7345-7429
Sergio Marco SalasScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-4636-0322
Louis B KuemmerleInstitute of Computational Biology, Helmholtz Munich, Neuherberg, Germany.
Xesús M AbaloScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-1643-0705
Alexandros SountoulidisScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8837-4642
Ludvig LarssonScience for Life Laboratory, Stockholm, Sweden.
Krishnaa T MahbubaniDepartment of Surgery, University of Cambridge, and Cambridge NIHR Biomedical Research Centre, Cambridge, UK.ORCID http://orcid.org/0000-0002-1327-2334
Jonas TheelkeScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-5074-1793
Zaneta AndrusivovaScience for Life Laboratory, Stockholm, Sweden.
Leire Alonso GaliciaScience for Life Laboratory, Stockholm, Sweden.
Andreas LiontosScience for Life Laboratory, Stockholm, Sweden.
Tamás BalassaSynthetic and Systems Biology Unit, HUN-REN Biological Research Centre, Szeged, Hungary.
Ferenc KovacsSynthetic and Systems Biology Unit, HUN-REN Biological Research Centre, Szeged, Hungary.ORCID http://orcid.org/0000-0003-4512-4448
Peter HorvathSynthetic and Systems Biology Unit, HUN-REN Biological Research Centre, Szeged, Hungary.
Yuexin ChenResearch Unit for Precision Regenerative Medicine (PRM), Helmholtz Munich, Neuherberg, Germany.
Janine Gote-SchnieringDepartment of Rheumatology and Immunology and Department of Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-7869-4936
Mircea-Gabriel StoleriuComprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), Munich, Germany.
Jürgen BehrComprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), Munich, Germany.
Kerstin B MeyerWellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.ORCID http://orcid.org/0000-0001-5906-1498
Wim TimensDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-4146-6363
Herbert B SchillerResearch Unit for Precision Regenerative Medicine (PRM), Helmholtz Munich, Neuherberg, Germany.
Malte D LueckenInstitute of Computational Biology, Helmholtz Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-7464-7921
Fabian J TheisInstitute of Computational Biology, Helmholtz Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-2419-1943
Joakim LundebergScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4313-1601
Mats NilssonScience for Life Laboratory, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-9985-0387
Martijn C NawijnDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-3372-6521
Christos SamakovlisScience for Life Laboratory, Stockholm, Sweden. christos.samakovlis@su.se.ORCID http://orcid.org/0000-0002-9153-6040

Funding

Cancerfonden (Swedish Cancer Society) 21 1794 P=1HVetenskapsrådet (Swedish Research Council) 2019-04893
6 · The paper itself

Abstract

Integration of scRNA-seq data from millions of cells revealed a high diversity of cell types in the healthy and diseased human lung. In a large and complex organ, constantly exposed to external agents, it is crucial to understand the influence of lung tissue topography or external factors on gene expression variability within cell types. Here, we apply three spatial transcriptomics approaches, to: (i) localize the majority of lung cell types, including rare epithelial cells within the tissue topography, (ii) describe consistent anatomical and regional gene expression variability within and across cell types, and (iii) reveal distinct cellular neighborhoods in specific anatomical regions and examine gene expression variations in them. We thus provide a spatially resolved tissue reference atlas in three representative regions of the healthy human lung. We further demonstrate its utility by defining previously unknown imbalances of epithelial cell type compositions in chronic obstructive pulmonary disease lungs. Our topographic atlas enables a precise description of characteristic regional cellular responses upon experimental perturbations or during disease progression.

Indexed as

LungPulmonary Disease, Chronic ObstructiveSingle-Cell AnalysisAtlases as TopicEpithelial CellsFemaleGene Expression ProfilingHumansMaleTranscriptome

Identifiers

PMID41193468
PMCPMC12589588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.